Lindsey B. Rosen
- Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
2021/08/10 by Paul Bastard, Adrian Gervais, Tom Le Voyer +97 · 1 voice · 31 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #SARS-CoV-2 and COVID-19 Research #COVID-19 Clinical Research Studies #Diabetes and associated disorders
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
2020/09/24 by Paul Bastard, Lindsey B. Rosen, Qian Zhang +97 · 1 voice · 26 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #COVID-19 Clinical Research Studies #Diabetes and associated disorders #SARS-CoV-2 and COVID-19 Research
- Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine
2021/02/05 by Paul Bastard, Eleftherios Michailidis, Hans-Heinrich Hoffmann +42 · 1 voice · 11 citations
Immunology and Microbiology · Medicine · #Immune Cell Function and Interaction #Mosquito-borne diseases and control #interferon and immune responses
- The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
2022/05/16 by Jérémy Manry, Paul Bastard, Adrian Gervais +97 · 1 voice · 5 citations
Medicine · #COVID-19 Clinical Research Studies #Long-Term Effects of COVID-19 #SARS-CoV-2 and COVID-19 Research
- Performance of expanded diagnostic criteria for APECED in independent cohorts and implications for earlier diagnosis
2026/07/21 by Elise M. N. Ferré, Joseph Pechacek, Monica M. Schmitt +33 · 1 voice
Medicine · Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · #Adrenal Hormones and Disorders #Diabetes and associated disorders #Immunodeficiency and Autoimmune Disorders